Dataset Information


A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.

ABSTRACT: Chimeric proteins joining the histone methyltransferase MLL with various fusion partners trigger distinctive lymphoid and myeloid leukemias. Here, we immunopurified proteins associated with ENL, a protein commonly fused to MLL. Identification of these ENL-associated proteins (EAPs) by mass spectrometry revealed enzymes with a known role in transcriptional elongation (RNA polymerase II C-terminal domain kinase [RNAPolII CTD] positive transcription elongation factor b [pTEFb]), and in chromatin modification (histone-H3 methyltransferase DOT1L) as well as other frequent MLL partners (AF4, AF5q31, and LAF4), and polycomb group members (RING1, CBX8, and BCoR). The composition of EAP was further verified by coimmunoprecipitation, 2-hybrid analysis, pull-down, and colocalization experiments. Purified EAP showed a histone H3 lysine 79-specific methylase activity, displayed a robust RNAPolII CTD kinase function, and counteracted the effect of the pTEFb inhibitor 5,6-dichloro-benzimidazole-riboside. In vivo, an ENL knock-down diminished genome-wide as well as gene-specific H3K79 dimethylation, reduced global run-on elongation, and inhibited transient transcriptional reporter activity. According to structure-function data, DOT1L recruitment was important for transformation by the MLL-ENL fusion derivative. These results suggest a function of ENL in histone modification and transcriptional elongation.


PROVIDER: S-EPMC2234781 | BioStudies | 2007-01-01

REPOSITORIES: biostudies

Similar Datasets

2011-01-01 | S-EPMC3038424 | BioStudies
2013-01-01 | S-EPMC3798529 | BioStudies
1000-01-01 | S-EPMC3169135 | BioStudies
2017-01-01 | S-EPMC5409830 | BioStudies
2018-01-01 | S-EPMC6142068 | BioStudies
2018-01-01 | S-EPMC6503841 | BioStudies
2013-01-01 | S-EPMC3593849 | BioStudies
1000-01-01 | S-EPMC3190787 | BioStudies
2013-01-01 | S-EPMC4124133 | BioStudies
2010-01-01 | S-EPMC3595998 | BioStudies